About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Treatment of Masked Hypertension | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT02142881

Treatment of Masked Hypertension

To date, most observational and all intervention studies have defined hypertension on the basis of clinic blood pressure (BP). Measurement of BP outside the clinic with home or ambulatory BP provides ...

Lead sponsor: University of Minnesota•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

University of Minnesota

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Age 18-75 years
•30 \< eGFR \< 70 ml/min/1.73m2 within 9 months of the screening visit
•Urine albumin to creatinine ratio \>100mg/gm OR a urinalysis with ≥30mg/dL albuminuria within 9 months of the screening visit
•Most recent clinic systolic BP \>120 and \<140 mmHg within 9 months of the screening visit
•Masked hypertension at the screening and baseline visits
•Clinic systolic BP \<140 mmHg
•24hr ambulatory systolic BP \> 130 mmHg
•Taking ≤ 2 antihypertensive medications
•No change in antihypertensive medications for the past 6 months

Exclusion Criteria

•Heart failure
•Lightheaded with standing
•Loss of consciousness in the past 24 months
•Non-English speakers
•History of breast cancer requiring a mastectomy or radiation on the side of the non-dominant arm and unable or refuses to use the dominant arm for ambulatory BP monitoring
•Cardiovascular event or procedure or hospitalization for unstable angina within the last 3 months
•Inability to perform ambulatory BP monitoring due to compliance or other clinical reason

Related studies

Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women

NCT06647511 · Gestational Hypertension

RECRUITINGPhase 1/2

Feasibility of Semaglutide in Advanced Lung Disease

NCT05746039 · Obesity, Interstitial Lung Disease, and more

Exploration of Systemic and Portal Hemostasis in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Placement

NCT07439939 · Liver Cirrhosis, Portal Hypertension

RECRUITINGPhase 3

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

NCT07218029 · Pulmonary Arterial Hypertension

Health Warnings and Counseling for Smoking Cessation

NCT07098065 · Tobacco Cessation, Health Warning Label, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 29, 2017Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment4

Start dateJun 2014

Last updatedDec 29, 2017

Condition

Masked Hypertension Hypertension Chronic Renal Insufficiency

Locations shown

University of Minnesota

Minneapolis, Minnesota

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 29, 2017Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions